Glomerulosclerosis

There are 100 papers on glomerulosclerosis in aging research: 13 observational studies in people, 66 in animals, 18 reviews. The newest story, Oct 30, 2026: “Mice lacking an enzyme retained kidney function with age”.

Disease

100 papers study it63 more mention it27 findings

5 new papers in 30 daysSee all 163 papers on glomerulosclerosis

“Higher transcript expression for NLRP3 in human glomeruli was accompanied by reduced podocyte density and increased global glomerulosclerosis and glomerular volume.”
Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-spanAging2023doi:10.18632/aging.204897
  • Humans13
  • Animals66
  • In silico2

Interventions

13

GYY4137

downin rats1

1 study
  1. GYY4137 decreases glomerulosclerosis in rats (12-month group) (mild glomerulosclerosis, diminished, not quantified).

    Animals12-month groupkidneymales

More on GYY4137

Sparsentan

downin mice1

1 study
  1. Sparsentan decreases glomerulosclerosis in mice (autosomal-recessive Alport mouse model) (significantly delayed).

    Animalsautosomal-recessive Alport mouse model

More on Sparsentan

Nicotinamide mononucleotide

downin mice1

1 study
  1. Nicotinamide mononucleotide decreases glomerulosclerosis in adriamycin-treated mice.

    Animalsin adriamycin-treated micekidney14 consecutive days

More on Nicotinamide mononucleotide

Empagliflozin

downin rats1

1 study
  1. Empagliflozin decreases glomerulosclerosis in rats (hypertensive T2DN rats; empagliflozin alone or combined with lisinopril).

    Animalshypertensive T2DN rats; empagliflozin alone or combined with lisinoprilkidney

More on Empagliflozin

MIRNA-503-5P inhibitor

downin mice1

1 study
  1. MIRNA-503-5P inhibitor decreases glomerulosclerosis in mice (administered with PEI-NPs in SAMP1 mice).

    Animalsadministered with PEI-NPs in SAMP1 micePEI-NPskidney5 nmol

More on MIRNA-503-5P inhibitor

Diphtheria toxin

upin mice1

1 study
  1. Diphtheria toxin increases glomerulosclerosis in mice (podocyte depletion induced by diphtheria toxin, marked glomerular pathology).

    Animalspodocyte depletion induced by diphtheria toxin, marked glomerular pathologyglomerulus

More on Diphtheria toxin

Resveratrol

downin mice1

1 study
  1. Resveratrol protects against glomerulosclerosis in mice (concanavalin A-induced kidney injury).

    Animalsconcanavalin A-induced kidney injurykidney30 mg/kgmales

More on Resveratrol

mTORC1 inhibitors

downin mice1

1 study
  1. mTORC1 inhibitors decrease glomerulosclerosis in Ercc1-deficient mice.

    Animalsin Ercc1-deficient micekidney

More on mTORC1 inhibitors

Sodium hydrosulfide

downin mice1

1 study
  1. Sodium hydrosulfide decreases glomerulosclerosis in old mice given NaHS for 5 months.

    Animalsin old mice given NaHS for 5 monthskidney30 μmol/L5 monthsmales

More on Sodium hydrosulfide

Elamipretide

downin mice1

1 study
  1. Elamipretide decreases glomerulosclerosis in mice.

    Animalsglomerulus8 weeks

More on Elamipretide

All 13

Upstream

11

SIRT1

no changein mice1downin mice1

2 studies
  1. SIRT1 showed no clear effect on glomerulosclerosis in mice (SIRT1 H355Y catalytically inactive knock-in (Sirt1Y/Y) versus wild-type mice).

    AnimalsSIRT1 H355Y catalytically inactive knock-in (Sirt1Y/Y) versus wild-type miceglomerulus

  2. SIRT1 protects against glomerulosclerosis in mice (shown by inducible podocyte-specific knockdown in aged mice).

    Animalsshown by inducible podocyte-specific knockdown in aged micekidney

More on SIRT1

Cellular senescence

upin reviews1

1 study
  1. Cellular senescence increases glomerulosclerosis.

    Reviewin podocytes, via the senescence-associated secretory phenotype and structural and functional impairment

More on Cellular senescence

PTGES2

upin mice1

1 study
  1. PTGES2 increases glomerulosclerosis in mice (shown by genetic ablation (knockout)).

    Animalsshown by genetic ablation (knockout)kidney

    Removing an enzyme eased kidney aging and bone loss in mice

    Aging cell

More on PTGES2

SHC1

upin mice1

1 study
  1. SHC1 increases glomerulosclerosis in mice (shown by knockout (p66Shc-/-)).

    Animalsshown by knockout (p66Shc-/-)kidney

More on SHC1

MAP3K5

upin mice1

1 study
  1. MAP3K5 increases glomerulosclerosis in mice (aging; shown by Ask1 knockout).

    Animalsaging; shown by Ask1 knockout

More on MAP3K5

Earlier experimental FSGS

upin mice1

1 study
  1. Earlier experimental FSGS increases glomerulosclerosis in mice (at middle age, in mice with FSGS induced when young, versus age-matched mice without FSGS).

    Animalsat middle age, in mice with FSGS induced when young, versus age-matched mice without FSGSglomerulus

More on Earlier experimental FSGS

ERCC1D/-

upin mice1

1 study
  1. ERCC1D/- increases glomerulosclerosis in progeroid Ercc1d/- mice.

    Animalsin progeroid Ercc1d/- micekidney

More on ERCC1D/-

REST

downin mice1

1 study
  1. REST decreases glomerulosclerosis in mice (shown by podocyte-specific deletion).

    Animalsshown by podocyte-specific deletion

More on REST

Klotho

downin mice1

1 study
  1. Klotho decreases glomerulosclerosis in mice (diabetic db/db mice).

    Animalsdiabetic db/db miceadenoviral overexpressionkidney

More on Klotho

ERCC1

downin mice1

1 study
  1. ERCC1 protects against glomerulosclerosis in mice (podocyte-specific Ercc1 knockout).

    Animalspodocyte-specific Ercc1 knockoutpodocyte

More on ERCC1

All 11

Associations

2

NLRP3

upin humans1

1 study
  1. NLRP3 is associated with glomerulosclerosis in humans (higher NLRP3 transcript expression in human glomeruli).

    Humanshigher NLRP3 transcript expression in human glomeruliglomerulus

More on NLRP3

P16 staining

upin F. catus1

1 study
  1. P16 staining is associated with glomerulosclerosis in F. catus.

    Animalsrenal cortex and corticomedullary junction

More on P16 staining

Trial sponsors

  • Amgen

    Company1 trialPhase 246 people

Funding

1 grant since 2025

Japan Society for the Promotion of Science¥4.7M

Latest

Dec 2025: 4Jan 2026: 3Feb 2026: 3Mar 2026: 3Apr 2026: 0May 2026: 1Jun 2026: 2Jul 2026: 3Aug 2026: 1Sep 2026: 4Oct 2026: 3Nov 2026: 330 papers in 12 months
Clinical Science

Mice lacking an enzyme retained kidney function with age

Kidney filtration declined by 25% in normal mice between 3 and 23 months, while mice lacking the enzyme were protected against this decline.Kidney filtration declined by 25% in normal mice between 3 and 23 months, while mice lacking the enzyme were protected against this decline.

Mouse studyKidney
Aging Cell

Removing an enzyme eased kidney aging and bone loss in mice

Deleting the enzyme’s gene in kidney filtering cells reduced kidney damage and age-related bone loss in aged mice; a drug also improved kidney and bone measures.Deleting the enzyme’s gene in kidney filtering cells reduced kidney damage and age-related bone loss in aged mice; a drug also improved kidney and bone measures.

Mouse studyBones and joints

See all 163 papers on glomerulosclerosis